In order to explore the mechanism of immune evasion in NSCLC and find new therapeutic targets for NSCLC, we firstly investigated the role of SNF5 in human NSCLC and found that the expression of SNF5 was up-regulated in human lung cancer tissues and was associated with poor prognosis. Here, SMARCB1 is linked to lung cancer.